Product NDC: | 0574-0014 |
Proprietary Name: | Erythra-Derm |
Non Proprietary Name: | Erythromycin |
Active Ingredient(s): | 20 mg/mL & nbsp; Erythromycin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0574-0014 |
Labeler Name: | Paddock Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062687 |
Marketing Category: | ANDA |
Start Marketing Date: | 19880228 |
Package NDC: | 0574-0014-02 |
Package Description: | 1 BOTTLE in 1 CARTON (0574-0014-02) > 60 mL in 1 BOTTLE |
NDC Code | 0574-0014-02 |
Proprietary Name | Erythra-Derm |
Package Description | 1 BOTTLE in 1 CARTON (0574-0014-02) > 60 mL in 1 BOTTLE |
Product NDC | 0574-0014 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythromycin |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 19880228 |
Marketing Category Name | ANDA |
Labeler Name | Paddock Laboratories, Inc. |
Substance Name | ERYTHROMYCIN |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |